openPR Logo
Press release

Emerge Clinical Solutions Establishes Strategic Partnership With MedAxiom

03-06-2012 07:29 AM CET | Health & Medicine

Press release from: Emerge Clinical Solutions

/ PR Agency: Power Public Relations
(Dallas, Texas) March 2, 2012 – Emerge Clinical Solutions, the creator of premier clinical decision support software, today announced its strategic relationship with MedAxiom, a comprehensive subscription-based service provider and information resource exclusively for cardiology practices.

Emerge's real time clinical decision support solution helps doctors increase diagnosis efficiency and accuracy by filtering inclusive patient data through patented algorithms developed by Dr. William Daniel, chief medical officer. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent.

“It’s exciting to see the healthcare industry, especially practices, integrate the latest advances in technology that benefit both the physician and the patient. This holistic approach will help practices on multiple fronts and represents where the healthcare industry is trending,” says Chris Romeo, Vice President, Business Development, MedAxiom.

MedAxiom currently encompasses about 325 of the leading cardiology practices in the U.S. The community of practice executives, administrative leaders, physicians and business office teams strive to be more effective and efficient by sharing experiences and insights into the future of cardiology.

The strategic relationship was officially announced at the 2012 Cardiovascular Care Summit: Solutions for Thriving in a Time of Change, which took place Jan. 12-14 in Las Vegas. At the conference, Emerge CEO Scott Finfer spoke on “Electronic Clinical Decision Support to Improve Adherence to Guideline Recommended Therapies.”

“MedAxiom is an incredibly well respected leader within the cardiology field. We’re delighted to partner with them and continue introducing professionals to our clinical software suite, which we believe is a great product that makes practice management easier, improves both doctor and patient experiences, and ultimately saves lives,” said Finfer.

MedAxiom and Emerge both understand the critical importance of properly analyzing data to achieve the best possible results in patient care. A signature of MedAxiom’s business is its unique system of metrics that measure operational practice data and best practice strategies.

About Emerge Clinical Solutions
Emerge Clinical Solutions is the creator of software solution developed by cardiologists to help medical providers and administrators improve the quality of cardiologic care to combat the nation’s number one killer, cardiac diseases. The software helps doctors increase condition recognition rates for high-risk patients, which ensures that patients receive the appropriate care at the appropriate time.

By assisting doctors with advanced diagnosis Emerge prevents costly, time-consuming and inappropriate tests and procedures. Emerge software also identifies high risk conditions quicker and with more efficiency. Medical emergencies are avoided and addressed with outpatient procedures. This proactive technology reduces emergency room visits and time in intensive care or worse… death. To learn more, please visit www.emergecds.com

About MedAxiom
MedAxiom is one of the most valuable resources a cardiology practice can have. We are a comprehensive subscription-based service provider and information resource exclusively for cardiology practices. Our network has grown to over 300 practices representing 5,400 physicians across the U.S. MedAxiom is a community of cardiology practice executives, administrative leaders, physicians and business office teams that strive to be more effective and efficient through sharing of operational practice data, best practice business strategies, positive and negative experiences as well as insights into the future of cardiology.

MedAxiom’s services are anchored by cardiology-specific comparative statistical analysis and benchmark reporting on financial, operational, and clinical functions within the practice. We collect well over 600 data points covering all facets of cardiology practice operations. MedAxiom offers two types of memberships; one for practice administrators and key business leaders and one for business office and coding departments.

Emerge Clinical Solutions
3131 McKinney Ave. Suite 455
Dallas, Texas 75204

Jennifer Burns
jennifer@powerpublicrelations.com
936-718-7645

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerge Clinical Solutions Establishes Strategic Partnership With MedAxiom here

News-ID: 213041 • Views:

More Releases from Emerge Clinical Solutions

Emerge Hires Ori Zakin as New Chief Technology Officer and Opens International O …
(Dallas) September 18, 2013 – Emerge Clinical Decision Solutions, creator of premier cardiologic clinical decision support software, today announced Ori Zakin as the company’s new chief technology officer and the opening of a research and development office in Israel. Emerge is a real time clinical decision support solution that helps doctors increase efficiency of patient care. By running comprehensive patient data through a patented algorithm, Emerge performs more than 8,000 calculations
Emerge Clinical Decisions Solutions Joins Short List of CDS Software Certified b …
(Dallas) September 11, 2013 – Emerge Clinical Decision Solutions today announced its accreditation as the first cardiology-specific CDS software in the country to be certified for meaningful use. Emerge has been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program. This EHR software is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of
HeartPlace Adopts Emerge Clinical Decision Support for 25 Hospitals, 31 Clinics
(Dallas, Texas) November 9, 2012 – Emerge Clinical Solutions, the creator of premier clinical decision support software, today announced HeartPlace is adapting its software system in 31 clinics throughout the Dallas and Fort Worth areas. HeartPlace is the largest independent cardiology group in the United States and the largest cardiology group in the country to use electronic medicals records. HeartPlace has been using Nextgen for 8 years; the group implemented the
Oklahoma Heart Hospital Partners with Emerge to Add Clinical Decision Support to …
(Dallas, Texas) October 2, 2012 – Oklahoma hearts just got a little healthier. Emerge Clinical Solutions, the creator of premier clinical decision support software, today announced Oklahoma Heart Hospital (OHH) is adding its software systems to its North and South Campus hospitals as well as 60 health clinics. OHH operates state of the art facilities that are consistently rated as the best in the country. It was the first all digital

All 4 Releases


More Releases for MedAxiom

Cardiovascular Information System (CVIS) Market 2020 Precise Outlook - McKesso ( …
The Cardiovascular Information System (CVIS) Market report is the most important research for who looks for complete information on the Cardiovascular Information System (CVIS) market. The report covers all information on the global and regional markets including historic and future trends for market demand, size, trading, supply, competitors, and prices as well as global predominant vendor's information. The forecast market information, SWOT analysis, Cardiovascular Information System (CVIS) market scenario, and
Cardiovascular Information System(CVIS) Market Insights Shared In Detailed Repor …
The Cardiovascular Information System(CVIS) Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Cardiovascular Information System(CVIS) market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the
Bioabsorbable Stents Market 2019 : Detailed Analysis by Segmentation and Key Pla …
A stent is a metallic or a polymer tube implanted into the lumen of any blood vessel or a duct in order to keep the passage open. A variety of stents for different clinical conditions are available in the market. The leading players have entered into agreements and collaborations with other companies to enhance their strong position in the market. For example: in June 2014, STENTYS announced its agreement to
Bioabsorbable Stents Market 2019: Medtronic, Abbott Laboratories, Boston Scienti …
A stent is a metallic or a polymer tube implanted into the lumen of any blood vessel or a duct in order to keep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage
Bioabsorbable Stents Market By Competitors : Abbott Laboratories, B. Braun Melsu …
A stent is a metallic or a polymer tube implanted into the lumen of any blood vessel or a duct in order to keep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to allow the passage
Global Bioabsorbable Stents Market 2016:Polymeric Stents, Metallic Stents, Natur …
Latest industry research report on Bioabsorbable Stents. A stent is a metallic or a polymer tube implanted into the lumen of any blood vessel or a duct in order to keep the passage open. A variety of stents for different clinical conditions are available in the market. A stent implant is most commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are